Since TMZ acts as an alkylating agent, GBM acquires resistance to TMZ, which is controlled by the expression of DNA repair protein MGMT, which is a major obstacle to GBM treatment [91,92]. The gene discussed is XRCC6P5; the disease is glioblastoma.